跳至主要内容
临床试验/CTRI/2020/03/023861
CTRI/2020/03/023861尚未招募2 期

Efficacy of Majoon-e-Shahtara and Zimad in Tinea cruris – An Open Labelled Single Arm Interventional Clinical Study

National Institute of Unani Medicine1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2020年10月3日最近更新:

试验速览

阶段
2 期
状态
尚未招募
入组人数
30
试验地点
1
主要终点
Improvement in subjective parameters

研究概览

简要总结

Diagnosed cases of Tinea cruris fulfilling the inclusion criteria will be enrolled into clinical trial after obtaining written informed consent. All subjects will be given test drugs Majoon-e-Shahtara 7g orally twice daily with water (after meal) and Zimad for local application twice daily for 4 weeks, followed by  two weeks (35th and 42nd day) of post-trial follow ups for assessment of any relapse. Assessment of study outcome will be made on the basis of   observation of baseline and each follow up in the form subjective and objective parameters. The subjective parameters will be assessed with an arbitrary grading 4 – point Likert scale (where 0 = nil, 1 = mild, 2 = moderate and 3 = severe) accordingly objective parameters like photography of the lesions and KOH microscopy will be assessed on 0th (baseline) and on 4th week. Following two more follow ups will be made to assess any relapse of the trial effect.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Not Applicable

入排标准

年龄范围
20.00 Year(s) 至 50.00 Year(s)(—)
性别
All

入选标准

  • Clinically and microscopically diagnosed patient of Tinea cruris Patient of either gender Age group 20-50 years Patient who have agreed to sign the informed consent form.

排除标准

  • Patient below 20 years and above 50 years of age Pregnant and lactating women Patient with severe systemic and metabolic disorders Diabetic, HIV/AIDS or other immunocompromised patients Patient with concomitant skin disease like eczema and psoriasis Patient who are taking conventional medicine for Tinea cruris will be enrolled for the trial after a washed out period of 15 days.

结局指标

主要结局

Improvement in subjective parameters

时间窗: 28 days

次要结局

  • Improvement in objective parameters(28 days)

研究者

申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验

treatment of qooba (tinea cruris) with unani... | 临床试验